Risperidone approved for the treatment of serious behavioral problems in children with autism.
Scahill
Lawrence
L
Yale University. lawrence.scahill@yale.edu
Koenig
Kathleen
K
Carroll
Deirdre H
DH
Pachler
Maryellen
M
D014150:Antipsychotic Agents / Q000627:therapeutic use*; D001321:Autistic Disorder / Q000453:epidemiology*; D002648:Child; D002653:Child Behavior Disorders / Q000188:drug therapy* / Q000453:epidemiology* / Q000523:psychology; D002665:Child Psychiatry / Q000331:legislation & jurisprudence; D006801:Humans; D018967:Risperidone / Q000627:therapeutic use*; D014481:United States
D014150:Antipsychotic Agents; D018967:Risperidone